Onglyza Injury Attorneys
If you or your loved one has suffered serious health problems after taking the medication Onglyza, contact an Onglyza injury attorney at Farah & Farah as soon as possible. Currently, we are filing claims for victims against AstraZeneca, the manufacturer of Onglyza, to seek compensation for all damages patients suffered because of the drug.
Onglyza In The News
A lawsuit filed in Illinois’ Cook County Circuit Court alleges that use of Onglyza, a Type 2 diabetes medication manufactured by AstraZeneca, caused the death of a Chicago woman.
According to the October 29th filing, Rochelle Gibson claims her mother, Lillie Ree Gibson, was first prescribed Onglyza in 2010, and was diagnosed with heart failure the next year. After being hospitalized twice, Lillie Ree Gibson died in October 2013 from complications related to her heart condition. The lawsuit alleges that the drug is directly linked to the patient’s death.
Onglyza and Heart Problems
Onglyza, also known by the generic name saxagliptin, is prescribed to patients who suffer from Type 2 diabetes. But, concerns have been raised that the drug can lead to an increased risk of heart problems.
A 2013 study published in The New England Journal of Medicine, found a 27 percent increase in first time hospitalization for heart failure in patients who took Onglyza. The report also found “significant or near significant increases in all-cause mortality,” which included both cardiovascular and non-cardiovascular deaths.
In April 2015, the U.S. Food and Drug Administration (FDA) associated Onglyza with “significant or near-significant” increased risk of death from all causes, not just heart problems. The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) voted 14-to-1 to recommend that the Onglyza label be revised to include information about a potential heart failure risk.
Onglyza Also Linked to Pancreatic Cancer
Onglyza, the brand name for the drug saxagliptin, is classified as a DPP-4 inhibitor. The drug works by helping to increase the production of insulin while it reduces the amount of sugar produced by the liver. DPP-4 is an enzyme produced by your body that breaks down a hormone known as GLP-1. This hormone instructs the pancreas to produce more insulin.
Diabetics don’t have enough insulin in their bodies. Because of this, they have too much sugar in their blood. Onglyza was designed to prevent DPP-4 from breaking down GLP-1, allowing the pancreas to produce more insulin.
The U.S. Food and Drug Administration first approved Onglyza in 2009. But, a 2013 study in the medical journal Diabetics showed that DPP-4 inhibitors like Onglyza might actually increase a patient’s risk for developing pancreatic cancer. The study reviewed FDA reports through 2014 and found a higher risk of pancreatic cancer in people who took DPP-4 inhibitors than the normal population that didn’t.
Liability for Onglyza Side Effects
For several years, Onglyza was prescribed to thousands of patients unaware of the drug’s dangerous, life-threatening side effects. People trust drug companies to provide a product that will help, not hurt. AtraZeneca, the manufacturer of this drug, must be held accountable for injuring so many, and even causing the death of at least one person. Farah & Farah can help.
Drug manufacturers are required by law to warn doctors and patients about all the side effects – and potential side effects – of medications they release to the market. If you or a loved have taken Onglyza and were diagnosed with heart failure, pancreatic cancer, or any other serious medical issue, please contact us.
Damages in an Onglyza Lawsuit
No amount of money can end the suffering and pain endured after taking Onglyza. What a lawsuit can do is ease the financial burden these injuries put on you and your family. By contacting Onglyza injury lawyers at Farah & Farah, you’ll be able to pursue financial damages for:
- Cost of medical treatment
- Lost wages from missing work
- Punitive damages, like your pain and suffering
- Health costs associated with heart failure, pancreatic cancer, or other disease
Contact the Onglyza Injury Lawyers at Farah & Farah Today
The manufacturer of Onglyza may have kept important safety information from customers and health professionals. Don’t let anyone who has hurt you get away with it. Let Farah & Farah fight for you. Contact our office today to speak with one of our pharmaceutical litigation attorneys. We can explain the process of pursuing your legal rights and answer any question you might have.
Call us today at 855-797-9899 for a free consultation.
Need help now? Speak with a
Patient Advocate now: